Related references
Note: Only part of the references are listed.The ACTN3 577XX Null Genotype Is Associated with Low Left Ventricular Dilation-Free Survival Rate in Patients with Duchenne Muscular Dystrophy
Masashi Nagai et al.
JOURNAL OF CARDIAC FAILURE (2020)
Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial
Sven Dittrich et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy
Tatyana A. Meyers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Stabilization of Early Duchenne Cardiomyopathy With Aldosterone Inhibition: Results of the Multicenter AIDMD Trial
Subha V. Raman et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy
Rachele Adorisio et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study
Tadao Aikawa et al.
PEDIATRIC CARDIOLOGY (2019)
Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy
Akinori Nakamura
JOURNAL OF PERSONALIZED MEDICINE (2019)
Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy
Kan N. Hor et al.
NEUROMUSCULAR DISORDERS (2018)
Cardiac Phenotypes in Hereditary Muscle Disorders JACC State-of-the-Art Review
Eloisa Arbustini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cardiac Management of the Patient With Duchenne Muscular Dystrophy
Sujatha Buddhe et al.
PEDIATRICS (2018)
Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies
Mary Wang et al.
OPEN HEART (2018)
Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review
Basmah El-Aloul et al.
NEUROMUSCULAR DISORDERS (2017)
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
Subha V. Raman et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy A Randomized Clinical Trial
Marly Conceicao Silva et al.
JAMA CARDIOLOGY (2017)
Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril
Sophie Mavrogeni et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging
Jonathan H. Soslow et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)
Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
Zhi Yon Charles Toh et al.
PLOS ONE (2016)
The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy
A. Brunklaus et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2015)
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy Applying the MOGE(S) Classification
Mark R. Hazebroek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies
Christopher F. Spurney et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
COOPERATIVE INTERNATIONAL NEUROMUSCULAR RESEARCH GROUP DUCHENNE NATURAL HISTORY STUDY DEMONSTRATES INSUFFICIENT DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY
Christopher Spurney et al.
MUSCLE & NERVE (2014)
Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy
Brent J. Barber et al.
JOURNAL OF PEDIATRICS (2013)
All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
Gernot Schram et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
Laurence Viollet et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Outcomes of Cardiac Involvement in Patients with Late-Stage Duchenne Muscular Dystrophy under Management in the Pulmonary Rehabilitation Center of a Tertiary Referral Hospital
Sung Woo Kwon et al.
CARDIOLOGY (2012)
The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction in Middle Childhood and Adolescent Patients With Muscular Dystrophy
Hye Won Kwon et al.
KOREAN CIRCULATION JOURNAL (2012)
Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial
Gunnar M. Buyse et al.
NEUROMUSCULAR DISORDERS (2011)
Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance
Kan N. Hor et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2011)
Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study
Sophie Mavrogeni et al.
BMC NEUROLOGY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Carvedilol can Prevent Cardiac Events in Duchenne Muscular Dystrophy
Tsuyoshi Matsumura et al.
INTERNAL MEDICINE (2010)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Katharine Bushby et al.
LANCET NEUROLOGY (2010)
Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?
Michael D. Puchalski et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2009)
Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
Hitoko Ogata et al.
JOURNAL OF CARDIOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy
Larry W. Markham et al.
NEUROMUSCULAR DISORDERS (2008)
Pediatric Heart Failure Therapy with ??-Adrenoceptor Antagonists
Susan R Foerster et al.
PEDIATRIC DRUGS (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy
J. Rhodes et al.
PEDIATRIC CARDIOLOGY (2008)
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy:: 10 years' follow-up
Denis Duboc et al.
AMERICAN HEART JOURNAL (2007)
Left ventricular function and response to Enalapril in patients with Duchenne muscular dystrophy during the second decade of life
Claudio Ramaciotti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy
Hidemi Kajimoto et al.
CIRCULATION JOURNAL (2006)
Steroid therapy and cardiac function in Duchenne muscular dystrophy
LW Markham et al.
PEDIATRIC CARDIOLOGY (2005)
Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy
JL Jefferies et al.
CIRCULATION (2005)
Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy
D Duboc et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies
A Cittadini et al.
EUROPEAN HEART JOURNAL (2003)
Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy
CK Silversides et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
A remarkable medical story: Benefits of angiotensin-converting enzyme inhibitors in cardiac patients
ME Khalil et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
